Vyriad is a Minnesota-based biotechnology company that develops and commercializes oncolytic virus therapies for the treatment of cancer.
Business Model:
Revenue: $2.5M
Employees: 11-50
Address: 2900 37th Street NW
City: Rochester
State: MN
Zip: 55901
Country: US
Vyriad is a Minnesota-based biotechnology company that develops and commercializes oncolytic virus therapies for the treatment of cancer.
Contact Phone:
+15072890944
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 8/2018 | Seed Round | $0 |
Southeast Minnesota Capital Fund Southeast Minnesota Capital Fund |
5/2022 | Series B | $0 |
Mayo Clinic Regeneron Harry H. Stine Mirae Asset Southeast Minnesota Capital Fund Mayo Clinic Regeneron Harry H. Stine Mirae Asset Southeast Minnesota Capital Fund |
10/2019 | Series B | $24.4M |
Regeneron Pharmaceuticals Inc |
5/2019 | Venture Round | $9M | 11/2019 | Series B | $24.4M | 5/2022 | Series B | 5 | $29.5M |
Stine Seed Farms, Inc Mayo Clinic Mirae Asset Regeneron Pharmaceuticals Inc Southeast Minnesota Capital Fund Harry H. Stine Mayo Clinic Mirae Asset Global Investments Regeneron Southeast Minnesota Capital Fund |
8/2018 | Equity | 1 | $500k |
Southeast Minnesota Capital Fund |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|